At the first time, our results showed that the expression level of miR675, H19, HP1α, EGR1, PKM2, H-Ras were consistent in 10 cases of liver cancer patients and their upregulated expression rate added up to 100% (liver cancer tissue vs paracancerous liver tissue) (Figure 7A). This evidence concerns the gene HRAS and liver cancer.